Saturday, February 18, 2012 6:07:13 PM
Fundamentals are the sole driving force behind the technicals here... There wouldn't BE any technicals if it weren't for the fundamentals.
We are going up strictly based on the current filings, anticipation of future filings, leadership, BOD connections, company turnaround, potential relisting, product release, debt potentially gone, yada yada yada!!!
Technicals are meaningful for daytraders ONLY here. And the day trading TA wizards have been smoked by gap ups and major breakouts based on FUNDAMENTALS.
Don't get me wrong... Cause I'll trade other stocks solely on technicals but this stock HAS to be treated differently based on the fundamentals.
Just grab some more shares and ignore the noise IMO... And don't forget to enjoy the ride. ATRN!
We are going up strictly based on the current filings, anticipation of future filings, leadership, BOD connections, company turnaround, potential relisting, product release, debt potentially gone, yada yada yada!!!
Technicals are meaningful for daytraders ONLY here. And the day trading TA wizards have been smoked by gap ups and major breakouts based on FUNDAMENTALS.
Don't get me wrong... Cause I'll trade other stocks solely on technicals but this stock HAS to be treated differently based on the fundamentals.
Just grab some more shares and ignore the noise IMO... And don't forget to enjoy the ride. ATRN!
Do your own Due Diligence. Anything I post is NOT a recommendation to buy or sell a security BY ANY MEANS!
Recent PTIX News
- Protagenic Therapeutics Completes Phytanix Separation, Strengthens Balance Sheet and Repositions the Company Around PT00114 • ACCESS Newswire • 03/17/2026 12:00:00 PM
- Protagenic Therapeutics Upgrades from OTC Pink to OTCQB Venture Market • ACCESS Newswire • 03/10/2026 12:00:00 PM
- Results from Phase 1 Multiple-Dose Study of PT00114 • ACCESS Newswire • 12/09/2025 01:46:00 PM
- Protagenic Therapeutics Announces Receipt of Nasdaq Non-Compliance Notice • ACCESS Newswire • 11/27/2025 08:45:00 AM
- Protagenic Therapeutics Announces Completion of Enrollment and Dosing in Phase 1 MAD Study • ACCESS Newswire • 11/13/2025 01:22:00 PM
- Protagenic Therapeutics Announces Grant of new patent in Japan for its Modified Stilbenoid Program Drug Candidates • GlobeNewswire Inc. • 07/30/2025 12:30:00 PM
- Nasdaq Top 5 Premarket Losers • IH Market News • 05/20/2025 12:47:37 PM
- Protagenic Therapeutics Soars 190% on Merger to Launch Neuroactive Biopharma Firm • IH Market News • 05/19/2025 02:28:09 PM
- Nasdaq Top 5 Premarket Gainers • IH Market News • 05/19/2025 01:07:08 PM
